Intervac, L.l.c. - Net Worth and Insider Trading

Intervac, L.l.c. Net Worth

The estimated net worth of Intervac, L.l.c. is at least $0 dollars as of 2024-04-25. Intervac, L.l.c. is the 10% Owner of Emergent BioSolutions Inc and owns about 0 shares of Emergent BioSolutions Inc (EBS) stock worth over $0. Details can be seen in Intervac, L.l.c.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Intervac, L.l.c. has not made any transactions after 2011-04-18 and currently still holds the listed stock(s).

Transaction Summary of Intervac, L.l.c.

To

Intervac, L.l.c. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Intervac, L.l.c. owns 2 companies in total, including Aptevo Therapeutics Inc (APVO) , and Emergent BioSolutions Inc (EBS) .

Click here to see the complete history of Intervac, L.l.c.’s form 4 insider trades.

Insider Ownership Summary of Intervac, L.l.c.

Ticker Comapny Transaction Date Type of Owner
APVO Aptevo Therapeutics Inc 2016-08-01 10 percent owner
EBS Emergent BioSolutions Inc 2011-04-18 10 percent owner

Intervac, L.l.c. Latest Holdings Summary

Intervac, L.l.c. currently owns a total of 1 stock. Intervac, L.l.c. owns 0 shares of Emergent BioSolutions Inc (EBS) as of April 18, 2011, with a value of $0.

Latest Holdings of Intervac, L.l.c.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EBS Emergent BioSolutions Inc 2011-04-18 0 2.18 0

Holding Weightings of Intervac, L.l.c.


Intervac, L.l.c. Form 4 Trading Tracker

According to the SEC Form 4 filings, Intervac, L.l.c. has made a total of 0 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years. The most-recent trade in Emergent BioSolutions Inc is the sale of 7,000 shares on April 18, 2011, which brought Intervac, L.l.c. around $163,170.

Insider Trading History of Intervac, L.l.c.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Intervac, L.l.c. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Intervac, L.l.c. Ownership Network

Ownership Network List of Intervac, L.l.c.

No Data

Ownership Network Relation of Intervac, L.l.c.


Intervac, L.l.c. Owned Company Details

What does Aptevo Therapeutics Inc do?

Who are the key executives at Aptevo Therapeutics Inc?

Intervac, L.l.c. is the 10 percent owner of Aptevo Therapeutics Inc. Other key executives at Aptevo Therapeutics Inc include SVP & CFO Daphne Taylor , 10 percent owner Kevin C Tang , and See Remarks Soyoung Kwon .

Aptevo Therapeutics Inc (APVO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aptevo Therapeutics Inc (APVO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptevo Therapeutics Inc (APVO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aptevo Therapeutics Inc (APVO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aptevo Therapeutics Inc Insider Transactions

No Available Data

Intervac, L.l.c. Mailing Address

Above is the net worth, insider trading, and ownership report for Intervac, L.l.c.. You might contact Intervac, L.l.c. via mailing address: C/o East-west Resources Corporation, 12001 Glen Road, Rockville Md 20854.

Discussions on Intervac, L.l.c.

No discussions yet.